Non-Hodgkin's Lymphoma (NHL)

Oncology
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Fate Therapeutics
Fate TherapeuticsSAN DIEGO, CA
1 program
1
Single FT1050 treated UCB unitPhase 11 trial
Active Trials
NCT01527838CompletedEst. Nov 2013

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Fate TherapeuticsSingle FT1050 treated UCB unit

Clinical Trials (1)

NCT01527838Fate TherapeuticsSingle FT1050 treated UCB unit

Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit

Start: Jan 2012Est. completion: Nov 2013
Phase 1Completed

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
5m ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
5m ago

Office Administrator

SystImmune
5m ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
16m ago

Working Student Office Management Support (m/f/d)

Mindpeak
Hamburg
19m ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
19m ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)